Skip to main content

ORIGINAL RESEARCH article

Front. Bioeng. Biotechnol.
Sec. Industrial Biotechnology
Volume 13 - 2025 | doi: 10.3389/fbioe.2025.1542060

Intensification of Vero cell adherence to microcarrier particles during cultivation in a wave bioreactor

Provisionally accepted
Zhad Mazhed Zhad Mazhed 1*Vladislav Vasilenko Vladislav Vasilenko 1Aleksandra Siniugina Aleksandra Siniugina 1Konstantin Kaa Konstantin Kaa 1Anton Motov Anton Motov 1Kseniya Pokidova Kseniya Pokidova 1Yuriy Ivin Yuriy Ivin 1Anastasia Pinyaeva Anastasia Pinyaeva 1Yusuf Khapchaev Yusuf Khapchaev 1Konstantin Chernov Konstantin Chernov 1Aidar Ishmukhametov Aidar Ishmukhametov 1,2
  • 1 Chumakov Federal Scientific Center for Research and Development of Immune-and- Biological Products (RAS), Moscow, Russia
  • 2 Institute for Translational Medicine and Biotechnology, I.M. Sechenov First Moscow State Medical University, Moscow, Moscow Oblast, Russia

The final, formatted version of the article will be published soon.

    Vaccination is the most effective strategy for fighting viral diseases, with both live and inactivated vaccines remaining crucial despite advancements in subunit vaccine technologies. A key player in vaccine production is the Vero cell line, derived from the kidney cells of the African green monkey, which is essential for manufacturing vaccines against diseases like polio, rabies, yellow fever, and COVID-19. The efficiency of Vero cell cultivation directly impacts vaccine production [1], often utilizing bioreactors ranging from small (1–10 L) to large (up to several thousand liters). Wave-type bioreactors are commonly employed for initial cell propagation due to their simplicity. However, achieving uniform cell distribution on microcarriers in these systems poses challenges [2]. This study aims to evaluate intermittent stirring during the early cultivation stages to enhance Vero cell distribution and growth, potentially improving overall cultivation efficiency.

    Keywords: cell cultivation, microcarrier particles, Bioreactor technology, Vero Cells, Wave bioreactor, Cytodex-1, Vaccine production, upstream process development

    Received: 09 Dec 2024; Accepted: 27 Jan 2025.

    Copyright: © 2025 Mazhed, Vasilenko, Siniugina, Kaa, Motov, Pokidova, Ivin, Pinyaeva, Khapchaev, Chernov and Ishmukhametov. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Zhad Mazhed, Chumakov Federal Scientific Center for Research and Development of Immune-and- Biological Products (RAS), Moscow, Russia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.